{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-195360","form_type":"8-K","ticker":"HCA","cik":"0000860730","company_name":"HCA Healthcare, Inc.","filed_at":"2023-07-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.805963+00:00","generated_at":"2026-06-13T01:42:01.242418+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"HCA Healthcare Q2 2023 revenue $15.86B; EPS $4.29; raises 2023 guidance","bullets":["Revenue $15.861B, up 7% YoY; net income $1.193B, diluted EPS $4.29 (vs $3.90).","Adjusted EBITDA $3.056B; same facility admissions +2.2%, equivalent admissions +3.7%.","2023 guidance raised: revenue $63.25-$64.75B, EPS $17.70-$18.90.","Quarterly dividend $0.60/share, payable Sept 29 to holders of record Sept 15.","Repurchased 3.3M shares for $915M in Q2; $2.825B remaining authorization."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-195360","json":"https://secwatch.observer/filing/0001193125-23-195360.json","markdown":"https://secwatch.observer/filing/0001193125-23-195360.md","text":"https://secwatch.observer/filing/0001193125-23-195360.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/860730/000119312523195360/0001193125-23-195360-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/860730/000119312523195360/d536904d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T01:42:01.242418+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}